Deciphera Pharmaceuticals, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2024.

Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10 May 2024

Quick Takeaways

  • Deciphera Pharmaceuticals, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2024.
  • Headline metric: Return On Equity -50%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-1.4%</span>.
  • Most recent SEC facts end date: 06 May 2024.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2024-05-06) highlights Return On Equity -50.4%, Return On Assets -39.3%, and Operating Margin -118.1%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

44.3/100

Caution Confidence high

Return On Equity

-50%

Metric score 0.0/100

Return On Assets

-39%

Metric score 0.0/100

Financial Health

Current Ratio
4.19x
Quick Ratio
1.49x
Debt to Equity
0.31x

Strengths

Quick Ratio, Debt-to-equity, and Revenues YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-50%

YoY: -1.4%

Industry median: -43% (n=675)

View history

Return On Assets

-39%

YoY: +0.97%

Industry median: -47% (n=673)

View history

Operating Margin

-118%

YoY: -14%

Industry median: -121% (n=298)

View history

Current Ratio

4.19x

YoY: -26%

Industry median: 3.39x (n=667)

View history

Quick Ratio

1.49x

YoY: -9.1%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

0.31x

YoY: +13%

Industry median: 0.26x (n=530)

View history

Revenues YoY

27%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

-4.8%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -50% -1.4%
Return On Assets -39% +0.97%
Operating Margin -118% -14%

Financial Health

Metric Latest value YoY change
Current Ratio 4.19x -26%
Quick Ratio 1.49x -9.1%
Debt-to-equity 0.31x +13%

Growth

Metric Latest value YoY change
Revenues YoY 27%
NetIncomeLoss YoY -4.8%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 86,475,972 +10%
Common Stock, Shares, Outstanding 82,158,670 +4.6%
Common Stock, Value, Issued $821,000 +4.6%
Weighted Average Number of Shares Outstanding, Basic 87,388,106 +5.7%
Weighted Average Number of Shares Outstanding, Diluted 87,388,106 +5.7%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $174,910,000 +27%
Research and Development Expense $237,192,000 +22%
Costs and Expenses $381,458,000 +17%
Operating Income (Loss) $206,548,000 -9.2%
Nonoperating Income (Expense) $16,563,000 +103%
Earnings Per Share, Basic -2 -1.8%
Earnings Per Share, Diluted -2 -1.8%
Cash and Cash Equivalents, at Carrying Value $91,228,000 -20%
Accounts Receivable, after Allowance for Credit Loss, Current $32,684,000 +46%
Inventory, Net $26,032,000 +2%
Other Assets, Current $1,386,000
Assets, Current $349,937,000 -27%
Property, Plant and Equipment, Net $5,155,000 -21%
Operating Lease, Right-of-Use Asset $30,925,000 -13%
Assets $420,928,000 -23%
Accounts Payable, Current $19,459,000 -1.1%
Employee-related Liabilities, Current $7,918,000 -27%
Liabilities, Current $83,429,000 -0.58%
Operating Lease, Liability, Noncurrent $21,449,000 -14%
Liabilities $104,878,000 -3.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $98,000
Retained Earnings (Accumulated Deficit) $1,473,388,000 -15%
Stockholders' Equity Attributable to Parent $316,050,000 -28%
Liabilities and Equity $420,928,000 -23%
Share-based Payment Arrangement, Noncash Expense $10,174,000 -19%
Increase (Decrease) in Accounts Receivable $878,000
Net Cash Provided by (Used in) Operating Activities $54,585,000 -10%
Net Cash Provided by (Used in) Financing Activities $522,000 -100%
Net Cash Provided by (Used in) Investing Activities $62,631,000
Common Stock, Shares Authorized 125,000,000 0%
Common Stock, Shares, Issued 82,158,670 +4.6%
Common Stock, Par or Stated Value Per Share 0.01 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $91,228,000 -20%
Payments to Acquire Property, Plant, and Equipment $146,000 -59%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $190,137,000 -4.9%
Operating Lease, Liability, Current $3,574,000 +8.3%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Preferred Stock, Shares Outstanding 0
Depreciation, Depletion and Amortization $450,000 -26%
Share-based Payment Arrangement, Expense $48,263,000 -3.8%
Preferred Stock, Par or Stated Value Per Share 0.01 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY